Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Cartesian Therapeutics Inc (RNAC)

Cartesian Therapeutics Inc (RNAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Cartesian Therapeutics to Present Updated Data from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2nd Annual Cell Therapy for Autoimmune Disease Summit GlobeNewswire - Thu Nov 21, 6:00AM CST

RNAC : 16.84 (-0.59%)
Cartesian Therapeutics Announces New Employment Inducement Grants GlobeNewswire - Fri Nov 8, 6:05AM CST

RNAC : 16.84 (-0.59%)
Cartesian Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update GlobeNewswire - Thu Nov 7, 6:00AM CST

RNAC : 16.84 (-0.59%)
Cartesian Therapeutics Announces Presentation at the Upcoming 66th ASH Annual Meeting GlobeNewswire - Tue Nov 5, 8:00AM CST

RNAC : 16.84 (-0.59%)
Insider Stock Research: New Fortress Energy, Marvell, and More Quiver Quantitative, Inc. - Tue Oct 22, 2:14AM CDT

October has seen a flurry of insider trading activity across multiple sectors, with key executives making significant stock purchases. New Fortress Energy’s (

PLAY : 34.30 (+0.15%)
DKL : 39.71 (+0.20%)
RNAC : 16.84 (-0.59%)
COHR : 106.58 (+3.10%)
NEOG : 14.75 (-1.01%)
WOR : 39.61 (+2.59%)
NFE : 9.70 (+5.66%)
STTK : 1.0100 (-9.01%)
MRVL : 92.93 (+3.42%)
CAPR : 18.35 (-3.01%)
Cartesian Therapeutics Announces Presentation of Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2024 MGFA Scientific Session of the AANEM Annual Meeting GlobeNewswire - Tue Oct 15, 6:00AM CDT

RNAC : 16.84 (-0.59%)
Cartesian Therapeutics Announces New Employment Inducement Grants GlobeNewswire - Fri Oct 4, 6:05AM CDT

RNAC : 16.84 (-0.59%)

Barchart Exclusives

ELF’s Unusual Options Activity Is a Thing of Questionable Beauty Barchart - 1 hour ago
E.L.F. Beauty’s options volume on Wednesday was 7x the 30-day average. The affordable makeup and skincare company’s unusual options activity stood out as one investor questioned its revenues. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot